Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Dysrhythmias II: Classification of Tachyarrhythmias01:28

Dysrhythmias II: Classification of Tachyarrhythmias

Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
Dysrhythmias I: Introduction01:15

Dysrhythmias I: Introduction

Dysrhythmias refers to abnormalities in the heart's rhythm. They result from disruptions in the heart's electrical conduction system, which includes the sinoatrial(SA)node, atrioventricular(AV) node, the bundle of His, bundle branches, and Purkinje fibers.Definition and PathophysiologyDysrhythmias result from disorders of impulse formation, impulse conduction, or both. The heart contains specialized cells in the sinoatrial node, atrioventricular node, and the bundle of His and Purkinje fibers...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Survey analysis on the development and current status of pediatric digestive endoscopy over past 40 years].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2026
Same author

Does Aspirin Affect Extracellular Vesicles Involved in the Pathogenesis of Preeclampsia? A Systematic Review and Meta-Analysis.

Hypertension (Dallas, Tex. : 1979)·2025
Same author

Clinical course and mortality in older patients with COVID-19: a cluster-based study in Hong Kong.

Hong Kong medical journal = Xianggang yi xue za zhi·2022
Same author

Circulating syndecan-1 is reduced in pregnancies with poor fetal growth and its secretion regulated by matrix metalloproteinases and the mitochondria.

Scientific reports·2021
Same author

Extracellular Vesicles and Preeclampsia: Current Knowledge and Future Research Directions.

Sub-cellular biochemistry·2021
Same author

Female genital mutilation: Obstetric outcomes in metropolitan Sydney.

The Australian & New Zealand journal of obstetrics & gynaecology·2019
Same journal

Cholera outbreak in 1932 and a public education pamphlet on the prevention of cholera.

Hong Kong medical journal = Xianggang yi xue za zhi·2026
Same journal

The Hong Kong Hospital Authority reform: a historical perspective. Part 3: From organisation reform to improving clinical quality and population health.

Hong Kong medical journal = Xianggang yi xue za zhi·2026
Same journal

Medical history of Hong Kong. Part II: Healers in the maze: unravelling the myths of Kowloon Walled City practitioners.

Hong Kong medical journal = Xianggang yi xue za zhi·2026
Same journal

Practical aspects of interpreting N-terminal pro-B-type natriuretic peptide levels in diagnosing Kawasaki disease.

Hong Kong medical journal = Xianggang yi xue za zhi·2026
Same journal

Kidney health for all: caring for people, protecting the planet.

Hong Kong medical journal = Xianggang yi xue za zhi·2026
Same journal

Functional outcomes following mechanical thrombectomy beyond 6 hours after acute ischaemic stroke.

Hong Kong medical journal = Xianggang yi xue za zhi·2026
See all related articles

Related Experiment Video

Updated: May 12, 2026

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice
09:20

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice

Published on: July 5, 2021

Brugada syndrome.

Jessica Jellins1, Mitchell Milanovic, David-Joel Taitz

  • 1School of Medicine, Sydney, The University of Notre Dame Australia, 160 Oxford Street, Darlinghurst NSW 2010, Australia.

Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|March 29, 2013
PubMed
Summary
This summary is machine-generated.

Brugada syndrome, a genetic heart condition, poses a high risk of sudden cardiac death, particularly in young males. Diagnosis and treatment, including implantable cardioverter defibrillators, depend on symptoms, ECG, and genetic factors.

Keywords:
Brugada syndromeChannelopathiesDeath, sudden, cardiac

More Related Videos

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

Related Experiment Videos

Last Updated: May 12, 2026

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice
09:20

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice

Published on: July 5, 2021

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

Area of Science:

  • Cardiology
  • Genetics
  • Electrophysiology

Background:

  • Brugada syndrome, identified in 1992, is a significant cause of sudden cardiac death, predominantly affecting younger males.
  • Patients may be symptomatic (syncope, palpitations) or asymptomatic.
  • The condition is characterized by three distinct electrocardiographic patterns.

Purpose of the Study:

  • To provide a comprehensive review of Brugada syndrome.
  • To cover proposed mechanisms, epidemiology, clinical presentations, genetics, diagnosis, risk stratification, and treatment options.

Main Methods:

  • This review synthesizes existing literature on Brugada syndrome.
  • It examines diagnostic criteria, including electrocardiographic patterns and provocative drug testing.
  • Risk stratification methods and current treatment strategies are discussed.

Main Results:

  • Brugada syndrome is associated with a high risk of sudden cardiac death.
  • Electrocardiographic patterns can be spontaneous or induced by sodium channel blockers.
  • Risk stratification involves patient symptoms, ECG findings, family history, and electrophysiological studies.

Conclusions:

  • The only effective treatment for Brugada syndrome to date is an implantable cardioverter defibrillator.
  • Treatment decisions are guided by a thorough assessment of individual patient risk.
  • Further research into mechanisms and novel therapies is warranted.